Median length of time for orphan and non-orphan drugs for FDA approval 2015
This statistic displays the median length of time that orphan and non-orphan drugs needed for FDA approval as of 2015. Orphan drugs took an average of 10.1 months for FDA approval. Orphan drugs are used to target rare diseases or disorders, which in the United States is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the United States through the Orphan Drug Act of 1983.